The Library of Congress >  Researchers >  Search Finding Aids  >  Frances Oldham Kelsey papers, 1890-2016

Frances Oldham Kelsey papers, 1890-2016

Contact UsHelpSearch All Finding Aids
Access restrictions apply.Some or all content stored offsite.
ContainerContents
Part II: Subject File, 1902-2012 (continued)
Deputy director, 1979-1982 (continued)
(2 folders)
BOX II:116 Caffeine, 1966, 1978-1982, undated
BOX II:116 Carcinogenesis/teratology, 1963-1983, undated
BOX II:116 Carrisyn/Carrington Laboratories, Dallas, Tex., 1986-1996
(2 folders)
BOX II:116 Celebrex/Vioxx, 1999-2002
BOX II:117 Center for Drug Evaluation and Research, U.S. Food and Drug Administration
BOX II:117 General, 1997-2000, undated
BOX II:117 Reports, 1992-1995
(3 folders)
BOX II:117 Research Steering Committee
BOX II:117 1987-1988
(3 folders)
BOX II:118 1990-1991
BOX II:118 Time reporting system, 1997-1999
BOX II:118 Chelation therapy, 2001
BOX II:118 Chick embryo studies, 1962-1972
BOX II:118 Chloramphenicol (Chloromycetin), 1962-1967, 1996-1997
BOX II:118 Chymopapain (Discase), 1973-1976, 1984, 1997-2000
BOX II:118 Chymotrypsin See Container II:140, Enzymes
BOX II:118 Clinical Investigator Conflict of Interest Task Force, U.S. Food and Drug Administration
BOX II:118 1987-1991
(3 folders)
BOX II:118 1992
(1 folder)
BOX II:119 (1 folder)
BOX II:119 1993-2000, undated
BOX II:119 Clinical trials, 1981, 1990, 1999, undated
BOX II:119 Clomiphene (Clomid), 1961-1989, undated
BOX II:119 Close, John H., 1977-1978, 1999
BOX II:119 Cobalt summary, Ray D. Uphoff and Albert L. Maduska, 1966, undated
BOX II:119 Cocaine, 1986-1997, undated
BOX II:119 Colestipol, 1971-1974
BOX II:119 Complementary and alternative medicine, 1996-2001, undated
BOX II:119 Compliance Policy Guides Manual (partial), microfiche, 1985
Microfiche shelf no. 22,656
BOX II:119 Compliance Program, evaluations reports, 1975-1977
BOX II:119 Computer-Assisted New Drug Applications
BOX II:119 General, 1980, 1988-1990, undated
BOX II:119 Guidance manual, 1992
BOX II:119 Confidentiality statute See Containers II:188-II:189, Privacy Act/Confidentiality statute
BOX II:120 Conflict of interest regulations, 1976-1978, circa 1993
BOX II:120 Congenital malformations review papers, 1957-1985, undated
(5 folders)
BOX II:120 Congressional
BOX II:120 Hearings
BOX II:120 House of Representatives
BOX II:120 Commission on the Federal Drug Approval Process (McMahon Commission)
BOX II:120 1981-1988
(4 folders)
BOX II:121 1996-1999, undated
(2 folders)
BOX II:121 Drug Safety, 1964
(2 folders)
BOX II:121 Fraud in biomedical research, 1981
BOX II:121 National Ambient Air Quality Standards, 1984
BOX II:121 Use of Advisory Committees by the U.S. Food and Drug Administration (Fountain Committee), 1982, 1997-1999
BOX II:121 Senate
BOX II:121 Interagency Coordination in Drug Research Regulation
BOX II:121 1961 See Oversize
BOX II:121 1962
BOX II:121 Mar.-May
BOX II:121 Aug.
(1 folder)
BOX II:122 (4 folders)
BOX II:122 1963
BOX II:122 Investigation of drug industry (Estes Kefauver), 1960-1964, 1997
BOX II:122 United States Government and the future of international medical research, 1961
BOX II:123 Miscellany
BOX II:123 Questions, undated
BOX II:123 Testimony, 1960-1961, 1970, 2000
(4 folders)
BOX II:123 Reports
BOX II:123 House of Representatives, circa 1963-1966
(2 folders)
BOX II:123 Office of Technology Assessment, 1974-1976
BOX II:124 Senate, 1960-1966
(2 folders)
BOX II:124 Consumer information publications by U.S. Food and Drug Administration, 1956-1988, undated
(4 folders)
BOX II:124 Contracts and Grants Review Committee, 1988-1989
(2 folders)
BOX II:124 Contracts for studies
BOX II:124 Auerbach Associates, FDA 72-63, 1972
BOX II:125 Center for Disease Control, possible contract, 1973
BOX II:125 Children’s Hospital Research Foundation, Cincinnati, Ohio
BOX II:125 FDA 68-44, FDA 70-7, FDA 71-11
BOX II:125 1967-1970
(7 folders)
BOX II:126 1971-1976
(5 folders)
BOX II:126 FDA 641-8-131, 1968
BOX II:126 Mayo Foundation, Rochester, Minn., FDA 72-339, FDA 7837-73(B)
BOX II:126 1971-1973
(2 folders)
BOX II:127 1974-1976
BOX II:127 National Academy of Sciences-National Research Council, FDA 70-22, FDA 71-52, FDA 72-1, 1970-1974, 1999
(2 folders)
BOX II:127 University of Miami, Miami, Fla.
BOX II:127 FDA 66-210, 1967-1968
BOX II:127 FDA 67-54, FDA 68-47, FDA 69-34
BOX II:127 1967-1970
(4 folders)
BOX II:128 1971-1975, 1999
BOX II:128 FDA 641-8-157, 1968-1973
BOX II:128 Control and dispensing of drugs, 1960-1963, 1996, undated
BOX II:128 Coulston Foundation, Alamogordo, N. Mex./Frederick Coulston, 1966, 1992, 1998-2000
BOX II:128 Daroil, 1964-1965
BOX II:128 Darvon, 1979-1980 See also Container II:139, Eli Lilly and Co. Task Group
BOX II:128 Data handling of scientific information, 1959-1964, 1995-1999, undated
BOX II:128 Day, J. Edward, 1965, 1996, undated
BOX II:128 Day, Paul L., 1961, 1999, undated
BOX II:128 Definition of terms “drug” and “new drug,” undated
BOX II:128 Defoliants and herbicides See Container II:186, Pesticides and environmental hazards
BOX II:128 DeMarco, Peter See Container II:189, Procaine with polyvinylpyrrolidone (PVP)
BOX II:128 Depo-Provera, 1966, 1975-1984, undated
BOX II:128 DES (Drug), 1953, 1972-2000, undated
BOX II:128 DFMO (Drug), 2000-2001
BOX II:128 DHSM (Drug) See same container, Dihydrostreptomycin
BOX II:128 Dicumarol and related anticoagulants, 1970-1986, 1996-1997
BOX II:128 “Diet” pills, 1985, 1997-2001, undated
BOX II:128 Dietary supplements, 1982, 1998-2001, undated
BOX II:128 Diethyl glycol See Container II:139, Elixir sulfanilamide
BOX II:128 Diethylstilbestrol See same container, DES (Drug)
BOX II:128 Difluoromethyl-ornithine See same container, DFMO (Drug)
Next Page »

Contents List